openPR Logo
Press release

The antibody contract manufacturing market is projected to reach USD 17 billion by 2030, growing at an annualized rate of 12%, claims Roots Analysis

12-31-2020 06:53 AM CET | Health & Medicine

Press release from: Roots Analysis

The antibody contract manufacturing market is projected

With over 100 therapeutic monoclonal antibodies and antibody-based products in the market, the demand for developing and manufacturing of such products is anticipated to increase beyond the capabilities of innovator companies alone

Roots Analysis has announced the addition of the “Antibody Contract Manufacturing Market, 2020-2030” report to its list of offerings.

Although biopharmaceuticals offer significant profit margins and have been proven to be effective in treating a myriad of diseases, they are generally associated with high costs of development and complex manufacturing protocols; this is true for antibody-based products as well. Presently, there are a number of companies that claim to offer end-to-end solutions, ranging from antibody development to commercial production. Further, prevalent trends suggest that sponsor companies are likely to continue relying on contract service providers for various aspects of antibody-based product development and manufacturing.

To order this 285+ page report, which features 100+ figures and 110+ tables, please visit this link- https://www.rootsanalysis.com/reports/view_document/antibody-cmo-market/295.html

Key Market Insights

Over 100 CMOs presently claim to offer manufacturing services for antibodies
The antibody contract manufacturing market is currently dominated by the presence of small and mid-sized companies, which represent 70% of the industry stakeholders. It is also worth highlighting that more than 55% of CMOs claim to have the capabilities to manufacture antibodies across all scales of operation (preclinical, clinical and commercial).

More than 90% service providers are focused on the production of monoclonal antibodies
However, players based in Asia are now increasingly focusing on the development of bispecific antibodies for therapeutic use. It worth highlighting that close to 20% of the CMOs engaged in this domain claim to offer manufacturing services for both bispecific antibodies and antibody fragments.

Europe has emerged as a key manufacturing hub for antibody-based products
More than 120 manufacturing facilities have been established by various players, worldwide; of these, 40% are in Europe. Additionally, 40% of the total installed capacity is in Europe, followed by Asia. Some of the prominent regions in Asia include (in decreasing order of number of manufacturing facilities) China, South Korea, India, Japan and Taiwan.

More than 90 partnership agreements have been inked between 2013 and 2019
Majority of these agreements were focused on manufacturing of various types of antibodies. Other popular types of collaboration models include process development and manufacturing agreements (22%), product development and manufacturing agreements (10%) and licensing agreements (7%).

Multiple expansion initiatives were undertaken by CMOs between 2017 and 2019
More than 50% of such initiatives were reported to be focused on the expansion of manufacturing facilities, followed by building new facilities (38%). It is worth noting that close to 50% of the total number of expansion initiatives were undertaken in Europe, of which, 25% were in the UK.

Demand for therapeutic antibodies is anticipated to grow at a CAGR of 10%, during 2020-2025
Given the fact that there are a number of antibody-based products in the market, the commercial demand for antibodies is significantly higher than the clinical demand. Across the three major global regions, North America represent over half of the overall global manufacturing demand for antibodies.

North America and Europe are anticipated to capture over 70% of the market share by 2030
However, the market in the Asia is anticipated to grow at a relatively faster rate. Further, presently, more than 90% of the antibodies are being developed using mammalian expression systems, and this trend is unlikely to change significantly in short to mid-term.

To request a sample copy / brochure of this report, please visit this link-
https://www.rootsanalysis.com/reports/view_document/antibody-cmo-market/295.html

Key Questions Answered
Who are the leading CMOs engaged in the production of antibody-based therapeutics?
What kind of partnership models are commonly adopted by stakeholders in this industry?
What is the annual clinical and commercial demand for antibody-based products?
What is the current installed capacity for manufacturing of antibodies?
What are the various expansion initiatives undertaken by antibody CMOs?
How is the current and future market opportunity likely to be distributed across key market segments?

The USD 17 billion (by 2030) financial opportunity within the antibody contract manufacturing market has been analyzed across the following segments:
Type of Antibodies
Monoclonal Antibodies
Bispecific Antibodies
ADCs
Others

Company Size
Small
Mid-sized
Large / Very Large

Scale of Operation
Preclinical / Clinical
Commercial

Type of expression system used
Mammalian
Microbial

Key geographical regions
North America
Europe
Asia and RoW

The report features inputs from eminent industry stakeholders, according to whom antibody therapeutics developers are increasingly outsourcing their manufacturing operations owing to complex nature of the overall process, as well as the high investments associated with setting-up in-house expertise. The report includes detailed transcripts of discussions held with the following experts:
Dietmar Katinger (Chief Executive Officer, Polymun Scientific)
David C Cunningham (Director, Corporate Development, Goodwin Biotechnology)
Claire Otjes (Marketing Manager, Batavia Biosciences)

The research covers profiles of key players that offer manufacturing services for antibodies, featuring a company overview, information on their respective service portfolios, manufacturing facilities and capabilities, and an informed future outlook.
AGC Biologics
Aldevron
AMRI
Boehringer Ingelheim BioXcellence
Emergent BioSolutions
Eurofins CDMO
FUJIFILM Diosynth Biotechnologies
KBI Biopharma
Lonza
Nitto Avecia Pharma Services
Novasep
Pierre Fabre
Samsung BioLogics
Synthon
Thermo Fisher Scientific

For additional details, please visit
https://www.rootsanalysis.com/reports/view_document/antibody-cmo-market/295.html or email sales@rootsanalysis.com

You may also be interested in the following titles:
1. Bispecific Antibody Therapeutics Market (4th Edition), 2019-2030
2. Antibody Drug Conjugates (ADCs) - Linker and Conjugation Technologies Market, 2019-2030
3. Antibody Drug Conjugates Market (5th Edition), 2019-2030

Contact:
Gaurav Chaudhary
gaurav.chaudhary@rootsanalysis.com

Roots Analysis
A430, 4th Floor,
Bestech Business Towers, Sector 66, Mohali, India
sales@rootsanalysis.com
+1 (415) 800 3415
+44 (122) 391 1091
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalys

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The antibody contract manufacturing market is projected to reach USD 17 billion by 2030, growing at an annualized rate of 12%, claims Roots Analysis here

News-ID: 2219343 • Views:

More Releases from Roots Analysis

ADME Toxicology Testing Market to Reach USD 6.0 Billion by 2030 at 3.9% CAGR | Charles River Laboratories, WuXi AppTec, Eurofins Scientific
ADME Toxicology Testing Market to Reach USD 6.0 Billion by 2030 at 3.9% CAGR | C …
The global in vitro ADME toxicology testing market, valued at USD 4.5 billion in 2025, is on track to reach USD 5.2 billion in 2026 and USD 6.0 billion by 2030, growing at a compound annual growth rate of 3.9% over the forecast period. Rising pharmaceutical R&D investment, tightening regulatory requirements for drug approvals, and a growing industry-wide shift toward outsourcing preclinical testing services are all pushing demand higher at
Tissue Engineering Market to Reach USD 12.7 Billion by 2035, Growing at 11.2% CAGR | Organogenesis, Integra LifeSciences, MiMedx
Tissue Engineering Market to Reach USD 12.7 Billion by 2035, Growing at 11.2% CA …
The global tissue engineering market, valued at USD 4.6 billion in 2025, will grow to USD 4.9 billion in 2026 and reach USD 12.7 billion by 2035, advancing at a compound annual growth rate of 11.2% through the forecast period. That trajectory reflects accelerating demand for regenerative therapies that can address chronic wounds, bone defects, and organ damage without the cost and complication burden that accompanies conventional transplantation. With more
Surgical Robots Market to Reach $22.9 Billion by 2035 at 8.9% CAGR | Intuitive Surgical, Medtronic, Johnson & Johnson
Surgical Robots Market to Reach $22.9 Billion by 2035 at 8.9% CAGR | Intuitive S …
The global surgical robots market, valued at USD 9.8 billion in 2025, will reach USD 10.6 billion in 2026 and climb to USD 22.9 billion by 2035, advancing at a compound annual growth rate (CAGR) of 8.9% across the 2026-to-2035 forecast window. That trajectory reflects sustained investment in robotic-assisted surgery platforms, a broad shift away from open surgical procedures toward minimally invasive techniques, and the accelerating integration of artificial intelligence
Spatial Genomics and Transcriptomics Market to Reach $20.1 Billion by 2035 at 11.9% CAGR | 10x Genomics, Akoya Biosciences, Bruker
Spatial Genomics and Transcriptomics Market to Reach $20.1 Billion by 2035 at 11 …
The global spatial genomics and transcriptomics market, valued at USD 6.5 billion in 2025, is on course to reach USD 7.3 billion in 2026 and USD 20.1 billion by 2035, expanding at a compound annual growth rate (CAGR) of 11.9% over the forecast period 2026 to 2035. This growth trajectory reflects accelerating demand for high-resolution tissue analysis technologies that preserve spatial context, a capability conventional molecular profiling methods have historically

All 5 Releases


More Releases for CMOs

1-Inch CMOS Sensor Camera Product Introduction
1. 1-Inch CMOS Sensor Camera Product Introduction A 1-Inch CMOS Sensor Camera is a camera that features a one-inch-sized CMOS image sensor as its core photosensitive element. This type of sensor boasts a larger light-capturing area, enabling it to gather more light, which results in superior image quality in low-light conditions, a higher dynamic range, and reduced noise. This means users can achieve clearer, more detailed images across a variety of
Industrial CMOS Image Sensor Market
Industrial CMOS Image Sensor Market Overview In industrial applications, one of the very important applications of CMOS image sensors is Automatic Optical Inspection (AOI, Automated Optical Inspection). In many applications such as display panel inspection, printed board inspection, etc, manual inspection is no longer competent, only relying on automatic optics.At the same time, new imaging architectures and new software algorithms are improving recognition speed and making the system more cost-effective. This report
X-ray CMOS Flat Panel Detector Market
The "X-ray CMOS Flat Panel Detector Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031.  The market was valued at USD xx.x billion In 2023. Growing Demand and Growth Potential in the Global X-ray CMOS Flat Panel Detector Market, 2024-2031 Verified Market Research's most recent report, "X-ray CMOS Flat Panel Detector Market: Global Industry Trends, Share, Size,
CMOS and sCMOS Image Sensors CMOS and sCMOS Image Sensors
The latest CMOS and sCMOS Image Sensors market study offers an all-inclusive analysis of the major strategies, corporate models, and market shares of the most noticeable players in this market. The study offers a thorough analysis of the key persuading factors, market figures in terms of revenues, segmental data, regional data, and country-wise data. Request a sample on this latest research report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5096977 Top Key Players are covered in this report:
Global In-vehicle Camera CMOS Market
Global In-vehicle Camera CMOS Market Overview: The latest report published by QY Research demonstrates that the global In-vehicle Camera CMOS market will showcase a steady CAGR in the coming years. The research report includes a thorough analysis of the market drivers, restraints, threats, and opportunities. It addresses the lucrative investment options for the players in the coming years. Analysts have offered market estimates at a global and a regional level. The research
Global CMOS Sensor Market Insights, Forecast
The CMOS Sensor market was valued at Million US$ in 2017 and is projected to reach Million US$ by 2025, at a CAGR of during the forecast period. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for CMOS Sensor Get sample copy of the report: https://www.marketdensity.com/contact?ref=Sample&reportid=49874 Table of Contents: Table of Contents 1 Study Coverage 1.1